Folding of lipid monolayers containing lung surfactant proteins SP-B1–25 and SP-C studied via coarse-grained molecular dynamics simulations  by Duncan, Susan L. & Larson, Ronald G.
Biochimica et Biophysica Acta 1798 (2010) 1632–1650
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemFolding of lipid monolayers containing lung surfactant proteins SP-B1–25 and SP-C
studied via coarse-grained molecular dynamics simulations
Susan L. Duncan, Ronald G. Larson ⁎
Dept. of Chemical Engineering, University of Michigan, 2300 Hayward St., 3074 H.H. Dow Building, Ann Arbor, Michigan 48109, USA⁎ Corresponding author. Tel.: +1 734 936 0772; fax:
E-mail address: rlarson@umich.edu (R.G. Larson).
0005-2736/$ – see front matter © 2010 Elsevier B.V. A
doi:10.1016/j.bbamem.2010.04.006a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 October 2009
Received in revised form 5 April 2010
Accepted 8 April 2010
Available online 14 May 2010
Keywords:
Pulmonary surfactant
Surfactant reservoir
Monolayer collapse
Surface aggregate
Order parameter
FluidizationTo explore the role of lung surfactant proteins SP-B and SP-C in storing and redelivering lipid from lipid
monolayers during the compression and re-expansion occurring in lungs during breathing, we simulate the
folding of lipid monolayers with and without these proteins. We utilize the MARTINI coarse-grained force
ﬁeld to simulate monolayers containing pure dipalmitoylphosphatidylcholine (DPPC) and DPPC mixed with
palmitoyloleoylphosphatidylglycerol (POPG), palmitic acid (PA), and/or peptides. The peptides considered
include the 25-residue N-terminal fragment of SP-B (SP-B1–25), SP-C, and several SP-B1–25 mutants in which
charged and hydrophilic residues are replaced by hydrophobic ones, or vice-versa. We observe two folding
mechanisms: folding by the ampliﬁcation of undulations and folding by nucleation about a defect. The ﬁrst
mechanism is observed in monolayers containing either POPG or peptides, while the second mechanism is
observed only with peptides present, and involves the lipid-mediated aggregation of the peptides into a
defect, from which the fold can nucleate. Fold nucleation from a defect displays a dependence on the
hydrophobic character of the peptides; if the number of hydrophobic residues is decreased signiﬁcantly,
monolayer folding does not occur. The addition of POPG or peptides to the DPPC monolayer has a ﬂuidizing
effect, which assists monolayer folding. In contrast, the addition of PA has a charge-dependent condensing
affect on DPPC monolayers containing SP-C. The peptides appear to play a signiﬁcant role in the folding
process, and provide a larger driving force for folding than POPG. In addition to promoting fold formation,
the peptides also display fusogenic behavior, which can lead to surface reﬁning.+1 734 763 0459.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Lung surfactant (LS) is a mixture of phospholipids, fatty acids,
neutral lipids, and surfactant proteins that forms the surface-active
lining in the lungs and decreases the work of breathing by reducing
and regulating the surface tension in the alveoli. Lung surfactant
consists of approximately 90% lipids and 10% proteins by weight [1].
Of the surfactant lipids, about 80% are phosphatidylcholines, about
half of which is dipalmitoylphosphatidylcholine (DPPC, phosphati-
dylcholine with two palmitic acid tails, also known as dipalmitoyl
lecithin or DPL) [1]. Infants born prematurely lack functional lung
surfactant and develop respiratory distress syndrome (RDS). Surfac-
tant replacements have greatly reduced the mortality rate of RDS, but
are not optimal [2]. In particular, acute respiratory distress syndrome
(ARDS), which can develop in adults, has proven difﬁcult to treat
using surfactant replacement therapy. A large amount of surfactant is
required to treat adults and exogenous surfactants are particularly
susceptible to inhibition by plasma components, which are commonly
present in ARDS patients due to underlying lung injury [3]. For thisreason, much effort has been placed on the development of low cost,
synthetic surfactants, designed to be inherently resistant to inactiva-
tion. However, further research is needed to understand the
mechanism by which lung surfactant is able to reduce and regulate
the surface tension in the lungs, in order to develop more efﬁcient
surfactant replacements.
To be effective, lung surfactant must display rapid adsorption, the
ability to compress to near-zero surface tension upon end-expiration,
and rapid respreading upon ﬁlm expansion [4]. The primary
component of lung surfactant, DPPC, is able to reduce the air–water
surface tension to nearly zero; however under physiological condi-
tions it is in a liquid-condensed (LC) phase, and thus is rigid and
exhibits poor respreadibility [5]. Other surfactant components
enhance the surface activity of LS. Unsaturated phospholipids, such
as palmitoyloleoylphosphatidylglycerol (POPG), ﬂuidize lung surfac-
tant surface ﬁlms increasing adsorption to the interface and are
thought to enhance respreading [1]. Neural lipids and fatty acids are
also present. Cholesterol constitutes (5–10 wt.%) of native surfactant.
It has been suggested that cholesterol modulates the phase behavior
of surfactant membranes by disordering phospholipids in the LC
phase and ordering phospholipids in the LE phase, resulting in the
formation of the liquid-ordered (Lo) and liquid-disordered (Ld)
phases, respectively [6]. Cholesterol is an important component of
1633S.L. Duncan, R.G. Larson / Biochimica et Biophysica Acta 1798 (2010) 1632–1650lung surfactant, but is systematically removed from some surfactant
replacements [6]. In contrast, palmitic acid (PA) constitutes only a
small fraction of native surfactants extracted by lavage (0–3 wt.%) [7],
but is used as an additive in surfactant replacements such as Surfacten
and Survanta to enhance ﬁlm stability [2].
Lung surfactant contains surface-associated surfactant proteins SP-
B and SP-C, which are highly hydrophobic and amphipathic. SP-B
contains seven cysteines, which form three intramolecular disulﬁde
bridges and an intermolecular one leading to the formation of a
homodimer [8]. The seven cysteine residues are strictly conserved
across all species, for which the sequence is known, suggesting that
the dimerization of SP-B has physiological signiﬁcance [3]. SP-B
contains more polar and hydrophilic residues than SP-C and is
therefore less hydrophobic. SP-C contains a valine-rich stretch of
hydrophobic residues, which is well conserved across species [3]. SP-C
also contains palmitoyl chains on cysteine residues 5 and 6 [9]. The
presence of these hydrophobic surfactant proteins is essential to
modulate the physical properties of the surface ﬁlm and to promote
the rapid formation of surface ﬁlms capable of reaching near-zero
surface tensions under repetitive cycling [10]. SP-B and SP-C
signiﬁcantly promote adsorption and are thought to promote
respreading of phospholipids to the interface; see Refs. [2,6] and
references therein. Electron micrographs of rabbit lungs [11] have
conﬁrmed the existence of a surface-associated surfactant reservoir,
which is thought to be essential for rapid respreading upon expansion.
The surfactant reservoir can form by either adsorption or collapse [2].
SP-B and SP-C have been shown to facilitate the formation of
reversible surface-associated 3-dimesional collapse structures [4,12–
31]. These collapse structures act as reservoirs, into which material is
inserted upon compression and fromwhichmaterial can be reversibly
reincorporated into the monolayer upon re-expansion. However, the
exact roles of SP-B and SP-C are still a matter of speculation. The
tertiary structure of SP-B is unknown; however the structure is known
for the 25-residue N-terminal fragment (SP-B1–25), which retains
most of the functionality of the full-length protein, including the
ability to form 3D collapse structures [12–16].
A common feature of almost all lung surfactants and model
mixtures is the coexistence of a semi-crystalline solid phase known as
the liquid-condensed (LC) phase and a disordered ﬂuid phase called
the liquid-expanded (LE) phase [32]. In the LC/LE phase coexistence
region, the surface ﬁlm becomes a mesh of ﬁnely divided LC/LE
domains, which may impart ﬁlm strength and ﬂexibility [33]. Liquid-
expanded regions provided ﬂuidity to normally rigid, condensed
DPPC ﬁlms, while condensed regions may act as “splints” in the
alveolar wall, preventing collapse with decreasing alveolar volume
[34]. It should be noted that lipids in the liquid-condensed phase (LC)
may be tilted or untilted. Lipids that are tilted are sometimes referred
to as tilted condensed (TC). Since all of the lipids in our simulations
are untilted, for simplicity the general term (LC) is used throughout
this paper to represent the condensed phase.
A prevalent theory known as the “squeeze-out” theory holds that
to reach near-zero surface tensions the monolayer surface must be
reﬁned through the “squeeze-out” of ﬂuidizing non-DPPC compo-
nents. The classical “squeeze-out” hypothesis states that non-DPPC
components such as unsaturated phospholipids are necessary to
enhance adsorption of DPPC to the interface, but these components
are selectively “squeezed out” during compression, leading to a
condensed monolayer that is highly enriched in the saturated
phospholipid DPPC [35–37]. Although the early reports on classical
“squeeze-out” suggested the possible existence of a “surface store”
[35] or “reservoir” [37], these reports were published before the ﬁrst
reports on the existence of hydrophobic surfactant proteins [38–41].
Later studies by Schürch et al. [11] and Post et al. [42], ﬁrst suggested
the existence of a peptide-promoted surface-associated surfactant
reservoir, in which surfactant material could be stored and remain
readily available for adsorption to the interface upon expansion. Thesestudies further suggested that the surfactant reservoir may be
enriched in non-DPPC components such as surfactant peptides and
unsaturated phospholipids, through either the selective adsorption of
DPPC to the interface [11] or the selective removal of non-DPPC
components from the interface upon compression [42]. There have
been a number of subsequent studies using the term “squeeze-out” to
describe the formation of reversible collapse structures, however
these studies do not necessarily imply that the monolayer is reﬁned to
become highly enriched in DPPC as held by classical “squeeze-out”
theory.
Some recent experimental observations undermine classical
squeeze-out theory; see Ref. [2] for a review. Experimental studies
involving spread ﬁlms suggest no signiﬁcant differences in lipid
composition between the multilayer, the adsorbed interfacial mono-
layer, and the surfactant in the bulk phase [43]. Additional studies
have shown that near-zero surface tensions can be obtained by ﬁlms
consisting of coexisting LC and LE phases [44]. Even monolayers
composed only of the unsaturated phospholipid palmitoyloleoylpho-
sphatidylcholine (POPC) have been shown to reach near-zero surface
tension, if compressed quickly enough [45]. Therefore the widely held
idea that to obtain low surface tension the surface has to be
compressed into tightly packed liquid-condensed or solid phase,
and therefore must be enriched in DPPC, is under substantial scrutiny.
A few theories have been proposed to explain the ability of ﬁlms
containing a signiﬁcant amount of LE phase to reach near-zero surface
tensions. In one such theory, the LE domains form a matrix in which
LC nanodomains are uniformly distributed, producing an alloy or
composite material that is both ﬂexible and stable [4]. This alloy
structure is thought to allow the partial collapse of themonolayer into
multilayers, without preventing the attainment of near-zero surface
tensions [4]. It has also been suggested that the 3D architecture of the
collapse structures may provide additional stability against further
collapse by acting as a skeleton or scaffold, thereby allowing the
attainment of lower surface tensions [3,17,46]. The proposal that SP-B
and SP-C may bridge the multilayer collapse structures to the
interfacial monolayer is consistent with this idea [2]. Hall and
coworkers [45,47,48] offer a different interpretation, that monolayers
compressed rapidly undergo a “supercompression” that is analogous
to the supercooling of 3D liquids toward a glass transition. Mono-
layers undergoing “supercompression” do not have enough time to
collapse and so form an amorphous structure that retains some
disorder, but exhibits the same stability against collapse as the LC
phase.
A mechanistic understanding of the ability of lung surfactant to
reach near-zero surface tension remains elusive. Therefore, the
structure and organization of lung surfactant in the low surface
tension regime is of particular interest. The collapse dynamics of
Langmuir monolayers, and speciﬁcally the role of proteins in the
formation and respreading of three-dimensional collapse structures,
remain somewhat mysterious, due in part to the richness of collapse
behavior observed under various conditions. This behavior includes
both reversible and irreversible collapse, collapse toward the air or
water subphase, the formation of crystallites, folds, vesicles, multi-
layers, and bilayer stacks. For more information on lung surfactant
structure and function, readers are referred to detailed reviews on the
phase behavior, collapse transitions, and biophysical properties of
lung surfactant [2,3,6,10,49–52].
Despite intensive research, the complex action of natural lung
surfactant remains poorly understood [53]. Computer simulations of
phospholipid systems are of great interest because they can yield
molecular-level insight into the structure and dynamics of these
systems at small spatial and temporal scales not accessible experi-
mentally. There are a few atomistic simulations that provide insight
into the orientation and interactions of SP-B1–25 in DPPC [54,55] and
PA [56,57] monolayers. Atomistic simulations of monolayer collapse
have also been performed for phospholipid [58] and fatty acid [59]
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196 arachidic acid molecules per monolayer) compressed by two
walls under a very large surface pressure (4426 mN/m) collapsed
either into the subphase or into the air side of the interface leading to
the formation of multilayers [59]. However the displacement of some
of the arachidic acid below the monolayer leading to the formation of
a multilayer on the air side of the interface is likely a consequence of
the extreme surface pressure. Atomistic simulations of small DPPC,
DPPC/POPG, DPPC/POPC, and DPPC/POPA monolayers (up to 64
lipids per monolayer) compressed to low lateral areas display
buckling and the loss of a few lipids from the monolayer [58].
However these monolayers are limited in their ability to produce
collapse structures by their small size, and are likely prone to system
size artifacts. In general, the length and time scales covered by
atomistic simulations are too small to overlap with experimental time
and distance scales, leaving a “no man's land” of intermediate spatial
and temporal scales that are not accessible either experimentally or
by atomistic simulations.
To help bridge part of this gap, much faster (around 1000-fold)
coarse-grained (CG) molecular simulations have been utilized in
which three or four heavy atoms (such as carbons) are lumped into a
single “bead”, whose interactions are tuned to capture those of the
group of atoms represented by the bead. Such simulations can achieve
longer time scales for larger system sizes than are readily attained
with atomistic simulations. In simulations performed by Nielsen et al.
[60] monolayers of CG short- and long-tail phospholipids (DC14PC and
DC29PC) exhibited collapsed into the air side of the interface
facilitated by a lipidic bridge transport mechanism. The collapse
mechanism observed was initiated under large negative surface
tensions (∼−300 mN/m) and displayed system size limitations. In
larger system size simulations (250 lipids per monolayer) extreme
curvature of the interface was evident and thought to be the onset of a
collapse transition into the subphase [60]. Baoukina et al. [61–63]
have applied the MARTINI CG model to study the collapse behavior of
DPPC [61], DPPC/POPG [62], and DPPC/POPG/cholesterol/SP-C [63]
monolayers. These simulations attained longer length and time scales
than the aforementioned atomistic and CG simulations and showed
that in response to relatively small negative surface tensions the
monolayers collapse into the water subphase by forming attached
bilayer folds. Baoukina et al. demonstrated the ability of the MARTINI
CG model to capture 2D to 3D transitions occurring at the monolayer
interface. However, the role (if any) that the proteins played in the
observed collapse was not clear. The role of proteins in reservoir
formation and maintenance still remains to be addressed through
molecular simulation. We therefore begin to address this role here.
The remainder of this paper is outlined as follows: ﬁrst, we provide
details of our simulations, then present the simulation results, and
ﬁnally compare them with experimental results. A preliminary
version of this work has been published as a meeting abstract [64].
2. Simulation methods
The MARTINI CG model [65,66] was used in all simulations
reported here. The CG mapping of DPPC, sodium ions, chloride ions,
and water molecules are the same as that provided in the topology
ﬁles on the MARTINI website [67]. The Perl script seq2cgtop_marti-
ni_v2.1tryout.pl [67] was used to generate the topology for the CG SP-
B1–25. The structure ﬁles for SP-B1–25 and SP-C were created by coarse-
graining structure ﬁles for SP-B1–25 [68] and SP-C [69] that were
obtained by FTIR and NMR spectroscopy. Because all of the lipid head
group and tail beads are of the same size, the lipids are always untilted
[70]. Marrink et al. have shown that tilted DPPC phases can be
simulated using the CG model, if the tail group bead size is decreased
by 10% [70]. The MARTINI model is parameterized based on
thermodynamic data, and has successfully reproduced membrane
properties such as area per lipid [65,71], pressure–area isotherms[72], phase transitions between lamellar and non-lamellar phases
[73,74], self assembly of bilayers, and structural and dynamic features
of protein–lipid interactions [66]. Furthermore, the MARTINI model
yields proﬁles of lateral pressure versus vertical position in the
monolayer that are qualitatively similar to those obtained from
atomistic simulations, suggesting that the MARTINI model captures
the essential lipid/solvent properties [75].
We use three system sizes; by laterally replicating the smallest
system size described below, we also built systems 4× and 9× larger
in area. For the smallest system size, each conﬁguration was
constructed from two disordered lipid monolayers (each composed
of 256 DPPC molecules) placed with heads facing each other across a
layer of water, and tails separated by vacuum, in a periodic box, as
described previously [72]. The z-dimension, normal to the layers, was
adjusted to 100 nm, which allows enough space for folding to occur
without the tail regions of the two monolayers interacting. The SP-
B1–25 molecules were then placed in eachmonolayer, oriented normal
to the interface with the insertion sequence, which is the last eight
residues on the N-terminus side, placed close to the head group
region. Four peptides were inserted into each monolayer in three
initial conﬁgurations: 1) with the peptides clustered together (not in
contact, but with each peptide ∼1.7 nm from the center of the box), 2)
in a line (separated by ∼3.3 nm), and 3) in a square (with each
peptide placed ∼4.5 nm from the center of the box). CG chloride ions
were then added to make the system electroneutral. The system was
then energy minimized. Larger system size simulations (4× or 9×)
were started from the square initial conﬁguration. Simulations of the
smallest system size were run using the all three initial conﬁgura-
tions; those containing SP-B1–25 were run from all three conﬁgura-
tions, those containing SP-C were run from square and cluster
conﬁgurations, and those containing mutants were run from line
and cluster conﬁgurations. The occurrence or absence of folding in
each peptide-containing monolayer was found to be consistent for all
initial conﬁgurations tested. All ﬁgures and folding times reported, for
the smallest system size, were obtained using the cluster initial
conﬁguration, unless otherwise noted.
All simulations with mutants were adapted from the cluster and
line conﬁgurations, by making substitutions, insertions, and deletions
of CG beads where necessary, and then performing energy minimi-
zation. The amino acid substitutions were chosen to adjust the
hydrophobicity of the selected residues while changing only mini-
mally the residue structure (e.g., the number of CG beads per residue,
or the presence of a ring structure). The parameters for the substitute
residues were taken from the amino acid topology ﬁle [67], without
altering any parameters associated with the secondary structure of
the peptide. The insertion sequence was removed from some of the
mutant peptides. Because the mutant peptides retained the same
positioning as SP-B1–25, these mutants were initially in contact with
the monolayer, but not embedded into the monolayer as much as the
other peptides. SP-C was placed in the monolayer in the samemanner
as SP-B1–25, but with the α-helix placed in the subphase initially tilted
with respect to the interface and with the palmitoyl chains inserted
into themonolayer. To test the effect of initial peptide conformation, a
monolayer containing SP-C with theα-helix initially embedded in the
lipid tail region was also simulated. The CG topology and structure
ﬁles for POPG were adapted from the lipid topology ﬁle and a
palmitoyloleoylphosphatidylethanolamine (POPE) bilayer CG struc-
ture ﬁle taken from the MARTINI website [67], by replacing the
ethanolamine head group bead (Qd) with a glycerol head group bead
(P4). A system containing two POPG monolayers was constructed in
the same way as for the DPPC monolayers. To create 1:1 DPPC:POPG
monolayers, POPG molecules were randomly replaced with DPPC
molecules to obtain a 1:1 mixture and the system was then energy
minimized. In mixtures containing PA, 42 DPPC molecules in each
monolayer were randomly replaced by PA molecules and the system
was then energy minimized. The topology and structure ﬁles for PA
Table 1
Simulations performed at 323 K and small negative surface tension (surface tension is
set to −5 mN/m). The compositions are given in mol:mol ratios.
Composition System size (per monolayer) Folding
DPPC 256 lipids No
DPPC with SP-B1–25 256 lipids and 4 peptides Yes
DPPC with SP-C 256 lipids and 4 peptides Yes
1:1 DPPC:POPG 256 lipids No
1:1 DPPC:POPG with SP-C 256 lipids and 4 peptides Yes
1:1 DPPC:POPG with SP-B1–25 256 lipids and 4 peptides Yes
∼5:1 DPPC:PA with SP-C 256 lipids and 4 peptides No
∼5:1 DPPC:PA with SP-B1–25 256 lipids and 4 peptides Yes
∼5:1 DPPC:PA (neutral) with SP-C 256 lipids and 4 peptides Yes
∼5:1 DPPC:PA (neutral) with SP-B1–25 256 lipids and 4 peptides Yes
∼5:1 DPPC:PA with depalmitoylated SP-C 256 lipids and 4 peptides Yes
DPPC 1024 lipids No
1:1 DPPC:POPG 1024 lipids Yes
DPPC with SP-B1–25 1024 lipids and 16 peptides Yes
DPPC 2304 lipids No
1:1 DPPC:POPG 2304 lipids Yes
DPPC with SP-B1–25 2304 lipids and 36 peptides Yes
DPPC with SP-C 2304 lipids and 36 peptides Yes
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glycerol bead (Na)with a (Qa) bead to reﬂect the anionic charge of PA.
For systems containing neutral PA, a P4 glycerol bead was used
instead, to represent the addition of a hydrogen. This headgroup bead
type was taken directly from the MARTINI topology ﬁle for palmitoyl
carboxylic acid.
Although the simulated peptide concentrations are larger than the
average physiological concentrations, as noted previously [76], local
concentrations of physiological lung surfactant components could be
much higher than the physiological average, particularly if interac-
tions between components result in non-uniform distributions.
For all simulations, temperature was maintained by coupling to a
Berendsen thermostat [77] with a 1 ps time constant. Berendsen
pressure coupling was used with a 1 ps time constant and all
compressibilities set to 5E–6 bar−1. For all simulations, a timestep of
0.02 ps was used, and periodic boundary conditions employed. All
simulations and analyses were performed using GROMACS simulation
software [78–80]. The trajectories were saved every 0.1 ns and used
for analysis. The following parameters were taken from the MARTINI
website [67] and have been optimized for the coarse-grained model:
short-range electrostatic and van der Waals cutoffs of 1.2 nm, with
van der Waals interaction shifting smoothly to Lennard Jones
interaction at 0.9 nm, and with the Lennard Jones cutoff set to
1.2 nm. The neighbor list was updated every 10 steps using a grid with
a 1.2 nm cutoff distance. In addition to the large computational speed
up, the molecular diffusivities of CG water and lipid molecules are
around four times higher than for atomistic ones. As a result, the
“effective time” of a simulation is roughly four times longer than the
“physical” time [65]. However, all times reported here are physical
times, as reported by the simulation.
Anisotropic pressure coupling was used for most of the simula-
tions. Surface tension (γ) is calculated according to the following
equation [61]:
γ tð Þ = Lz
2
Pzz tð Þ−
Pxx tð Þ + Pyy tð Þ
2
 
ð1Þ
where t is time, Lz is the length of the box in the z-direction, and Pxx,
Pyy, and Pzz are the pressures in the x, y, and z directions. Most of the
simulations were run at small negative surface tensions, with the
pressure in the x and y directions set to 1 bar, the off-diagonal
pressures to 0 bar, and the normal pressure (PN; equal to Pzz) to 0 bar
due to the vacuum between the monolayers. This corresponds to a
surface tension set to −5 mN/m; however due to pressure ﬂuctua-
tions the actual time-average surface tension differs slightly from this
set point. A limited number of simulations were also run with surface
tension set to zero, where pressure was coupled anisotropically to
0 bar in all directions. The average surface tension tends to be slightly
higher than the set point; for instance with surface tension set to
−5 mN/m, the average surface tension is just above 0 mN/m, and
when surface tension set 0 mN/m, the average surface tension a few
mN/m. The standard error is ∼1–2 mN/m. Our pressure ﬂuctuations
are similar to those reported previously [63]. Throughout the rest of
this paper all reported pressures are set point values rather than
actual pressures. To test the robustness of our results, a limited
number of isotropic (P=1 bar) and semi-isotropic (with a lateral
pressure PL=1 bar and normal pressure PN=0 bar) simulations were
also performed. For more details on each coupling mechanism the
reader is referred to the GROMACS User Manual [81] and relevant
simulation papers [82–86].
Monolayer re-expansion was simulated using semi-isotropic
pressure coupling with PN=0 bar and PL set to −5 bar and −10 bar.
As reported previously, at large values of surface tension, the box size
diverges and eventually explodes due to the onset of hole formation
followed by expansion and ultimately the rupture of the monolayer
[61,72,86–88].Our simulations were 500 ns in duration for the smallest system
size and 300 ns for the 4× and 9× larger systems. For the larger system
sizes, some simulations which displayed folding sooner than 300 ns
where stopped early. Unless stated otherwise, all simulations were
performed at 323 K and a small negative surface tension (−5 mN/m),
as described above. This temperature was chosen to allow the
development of thermal undulations in all monolayers including
DPPC monolayers, which are in the LE phase at this temperature.
The MARTINI model for DPPC consists of two headgroup beads,
two beads that represent the glycerol linkage, and eight tail group
beads (four per tail). Lipid tail beads are numbered in increasing order
as the distance from the headgroup increases (C1, C2, C3, …). For
phospholipids, a further designation is included to indicate whether
the tail bead is on chain A or chain B. Chain A is the chain attached to
the glycerol bead, which is directly bonded to the phosphate
headgroup bead, and chain B is attached to the other glycerol.
Measurements from experimental [89] and simulated [72] DPPC
monolayers show that the packing of the DPPC tails is much more
sensitive to changes in molecular area than is that of the PC
headgroup. For this reason the order of a phospholipid monolayer is
most commonly measured by studying the phospholipid tails. Here,
lipid tail order parameters were calculated every 0.2 ns between 10
and 20 ns of simulation time. Our results have shown that ∼10 ns of
equilibration is necessary to allow relaxation of the monolayer area.
Unless stated otherwise, the reported order parameters are averages
over all C2 tail sites in themixture. The average order parameter of the
C2A beads is slightly higher than that of the C2B beads. We found that
averaging over all C2 sites yielded similar trends as averaging over
C2A sites only, with only a very slight shift in magnitude. Also, order
parameters for C3 tail sites show similar, but weaker, trends than
those for C2 tail sites, but C3 sites are more disordered, and therefore
give lower order parameters than the C2 sites. These observations are
in agreement with atomistic simulations of DPPC monolayers [88],
which show that the order parameters for each tail CH2 group display
similar trends in response to changes in area per lipid, but differ
slightly in magnitude with the order decreasing toward the termini.
3. Results
3.1. Folding
We performed CG simulations of lipid and lipid/protein mono-
layers of varying composition at 323 K and small negative surface
tension (γ set to −5 mN/m), as listed in Table 1. Three system sizes
were used. The smallest system contained 256 lipidswith orwithout 4
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molecules per monolayer were also simulated. For the smallest
system, folding was not observed within 500 ns of simulation time for
the pure lipid monolayers (DPPC and 1:1 DPPC:POPG). Once the
system size was increased to the intermediate system size, the 1:1
DPPC:POPG monolayer did fold (Fig. 1a). In contrast, the pure DPPC
monolayer did not fold even for the largest system size (Fig. 1b). The
addition of SP-B1–25 or SP-C to DPPCmonolayers induced folding, even
for the smallest system size. Fig. 1 (c and d) illustrates folds formed in
DPPC monolayers containing SP-B1–25 at an intermediate system size.
The folds are ﬂat bilayers in one direction (Fig. 1d) and teardrop
shaped in the other (Fig. 1c).
For the smallest system, we observed folding for all of the mixed
protein–lipid monolayers except for the ∼5:1 DPPC:PA monolayers
containing SP-C (Supplementary material). In this case, the addition
of the palmitic acid eliminates the folding that is seen in the DPPC
monolayers containing only SP-C. In contrast, the addition of palmitic
acid does not restrict folding in the DPPC monolayers containing SP-
B1–25 (Fig. 1e) as it does for those containing SP-C. Unlike SP-B1–25, SP-Fig. 1. The occurrence or absence of folding in the simulated monolayers. (a) At an intermedia
(b) In contrast, even at the largest system size simulated (2304 lipids per monolayer) pure D
monolayers composed of 1024 DPPC and 16 SP-B1–25 molecules per monolayer and (e) in mo
folds formed in a DPPC monolayer containing SP-B1–25 are shown from the side and (d) fro
headgroups are blue, DPPC glycerol linkages are green, DPPC tails are turquoise, peptides a
transparent in some ﬁgures for clarity.C contains two palmitoyl chains. In order to test the effect of the
palmitoyl chains, we ran a simulation containing ∼5:1 DPPC:PA
monolayers with depalmitoylated SP-C and found that folding did in
fact occur once the palmitoyl chains were removed. Also, if PA is
neutralized by changing the bead type of the glycerol bead from Qa to
P4, folding occurs in all systems studied including the DPPC/PA
monolayers containing SP-C (Supplementary material). Interestingly,
once ∼5:1 DPPC:PA(neutralized) with SP-C have run for as little as
20 ns of simulation time (resulting in small undulations and loose
aggregation of the peptides), if the palmitic acid is suddenly
recharged, then folding still occurs. Thus, charged palmitic acid and
SP-C act together to suppress the initial ﬂuctuations needed for
folding. Even brief neutralization of PA sufﬁces to produce ﬂuctuations
of sufﬁcient size that folding will occur even if the PA is thereafter
recharged.
Monolayers containing 256 DPPC and 4 SP-B1–25 molecules were
started from conﬁgurations where the peptides were place clustered
together, in a line, and in a square, as described in Simulation methods.
Different pressure coupling methods (anisotropic, semi-isotropic andte system size of 1024 lipids permonolayer 1:1 DPPC:POPGmonolayers exhibit folding.
PPC monolayers do not fold within 300 ns of simulation time. (c–d) Folds also form in
nolayers composed of 214 DPPC, 42 PA and 4 SP-B1–25 molecules per monolayer. (c)The
m the front. In this and subsequent ﬁgures (including Supplementary material) DPPC
re yellow, POPG and PA are red and small dots represent the water subphase. DPPC is
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4 SP-B1–25 molecules. Monolayer folding was found to be robust,
occurring irrespective of pressure coupling method and initial conﬁg-
uration, and differing only in time scale. For instance, when the peptides
are placed further apart from one another, aggregation requires more
time, resulting in folding at later times. Decreasing the concentration of
SP-B1–25, however, decreases the perturbation of the monolayer and
slows or eliminates the folding. In DPPC monolayers containing only 3
SP-B1–25 molecules each, folding occurred more than 200 ns later than
the same system containing 4 SP-B1–25 molecules per monolayer. If the
concentration was further reduced to 2 SP-B1–25 permonolayer, folding
did not occur within the 500 ns of simulation time.Fig. 2. The occurrence of folding in two monolayers separated by water, containing 256 DP
centered around peptide aggregates form after 140 ns (not shown) and folds begin to grow.
(b) After 206 ns of simulation, peptides in folds from opposing monolayers interact with one
was started with peptides initially positioned at corners of a square.3.2. Peptide aggregation
For monolayers of the smallest system size, we observed peptide
aggregation, and found that a defect is required to nucleate a fold. The
aggregationof thepeptides canprovide suchadefect. Onceanaggregate
has formed, undulations centered on the aggregate begin to grow
(Fig. 2a) leading to fold formation. The aggregate typically forms a cap
on the monolayer fold and acts like a zipper pulling the surrounding
lipids into a bilayer fold. We ﬁnd that while some peptides are more
prone to aggregate (i.e., they display faster aggregation and more
compact aggregates) than others, even peptides that do not appear to
have a strong preference for aggregation exhibit some aggregation asPC and 4 SP-B1–25 molecules each. Periodic images are shown for clarity. Undulations
The peptides form a cap on the end of each fold. (a) After 190 ns, fold growth is evident.
another eventually leading to fusion of the two folds into a lipid bridge. This simulation
Table 2
Peptides used in folding simulations. Residues with a polar or charged side chain bead
are shown in red, those with non-polar (or apolar) side chains in blue, and those
without side chain beads in black. Amino acid substitutions have been underlined.
The termini have charged backbone beads and are shown in red. *The cysteines on
SP-C are palmitoylated.
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induced by the curvature of the monolayer.
In the simulations described in Tables 1 and 2, all peptides were
initially partially inserted at the interface but mostly in the water
subphase. The SP-B1–25 molecules (and mutants) were oriented
normal to the interface with the insertion sequence placed close to
the head group region. SP-C was placed with the palmitoyl chains
inserted into the monolayer and the rest of the protein protruding out
into the subphase and tilted with respect to the interface. The
peptides quickly move into the interface, and adopt a ﬁnal orientation
that is parallel to the interface. However, this interfacial orientation
could reﬂect a local energy minimum and not necessarily the
equilibrium orientation of the peptides. SP-B is thought to reside
near the headgroup region with its α-helix parallel to the interface
[90]. However, SP-C is highly hydrophobic and infrared reﬂection–
adsorption spectroscopy has revealed that SP-C adopts a tilted
orientation [91] embedded within DPPC monolayers. To test whether
the observed folding mechanism is dependent on the initial peptide
orientation, we placed four SP-C molecules within monolayers
containing 256 DPPC molecules with an initial SP-C orientation that
was tilted and embedded within the tail region (Supplementary
material). Once again the peptides aggregated and the aggregate
acted as a site around which fold nucleation occurred. In this case,
some of the peptides did not adopt a parallel orientation, but
remained embedded within the monolayer. Although the peptide
aggregate always acted as a nucleation site, it remained embedded in
one monolayer rather than forming a cap on the fold as typically seen
for peptides that are oriented parallel to the interface.
3.3. Mutants
DPPCmonolayers containing 256 lipids per monolayer exhibit fold
nucleation about a defect composed of either SP-B1–25 or SP-C. To
determine the peptide characteristics required for fold nucleation,
several SP-B1–25 mutants were created. The mutants, listed in Table 2,
were altered by replacing hydrophobic residues of the original SP-
B1–25 with hydrophilic ones or vice-versa, and/or by removing the
insertion sequence. In each simulation, four mutant peptides were
placed in a monolayer composed of 256 DPPC molecules, and
simulated under a small negative surface tension. The results indicatethat folding is a generic behavior that is not limited solely to the native
LS peptides, but is observed for many of the mutant peptides as well.
However, for folding to occur via nucleation about a peptide
aggregate, the peptides must be sufﬁciently hydrophobic. It is clear
from Table 2 that there is a strong correlation between the
hydrophobicity of the peptide and folding. If the number of
hydrophobic residues is decreased signiﬁcantly (to less than 10
hydrophobic residues, with the exception of MUT10 that contains
nine residues) the monolayer does not fold. If the insertion sequence
(the last eight residues on the N-terminus) is removed (MUT15), this
decreases the number of hydrophobic residues to 8, and folding does
not occur, at least not over the time scale of our simulation. The results
suggest that folding is a generic behavior that is not limited solely to the
native LS peptides. However, there are likely overlapping, but
distinctive, physiological roles for each hydrophobic surfactant protein
(SP-B and SP-C) at the interface, which the present simulations are
unable to detect.
Fig. 3 illustrates two cases in which folding does not occur. The
formation of a peptide aggregate is observed in all cases. In the case of
MUT11 (Fig. 3a) the insertion sequence is present but there are only
nine hydrophobic residues. Because there are few hydrophobic
residues outside of the insertion sequence, interactions between the
hydrophilic (polar or charged) residues and the water subphase are
dominant. The MUT11 aggregates are anchored to the monolayer by
the insertion sequence, but reside mostly in the water subphase and
perturb the monolayer very little. In the case of MUT16 (Fig. 3b) there
are only eight hydrophobic residues and no insertion sequence. The
hydrophobic residues are distributed throughout the peptide;
however the total number of hydrophobic residues is still small. The
aggregates of MUT16 have a clear perturbing effect on the monolayer,
which is evident within ∼170 ns of simulation time; however, folding
does not ensue within the 500 ns of the simulation.
3.4. Order parameters
The carbon-deuterium order parameter (−SCD) is deﬁned by
Eq. (2) [92], where the z-axis is normal to the monolayer, and the
order with respect to the x-direction (Sx) is deﬁned according to
Eq. (3) [81]. In Eq. (3), θx is deﬁned as the angle between the lipid tail
and the x-axis, and the brackets represent an average over time and
molecules. The order with respect to the y-direction (Sy) is similarly
deﬁned by replacing θx with θy.
SCD =
2
3
Sx +
1
3
Sy ð2Þ
Sx =
3
2
〈 cos2 θx〉−
1
2
ð3Þ
The carbon-deuterium order parameter (−SCD) indicates the order
of the lipid tails, which correlates strongly with monolayer ﬂuidity. A
value of 0.5 corresponds to a tail that is perfectly aligned parallel to
the monolayer normal and a value of 0 corresponds to an isotropic
(random) orientation.
To compare lipid tail order for the pure lipid and lipid–protein
monolayers the average order parameter (−SCD) of the lipid C2 tail
beads is obtained between 10 and 20 ns of simulation time, for each
system. This relatively short time window is chosen to allow the
system to relax from its starting state, but to avoid encompassing the
change in order parameter at later times associated with folding itself.
Fig. 4 shows the order parameter versus time for three representative
systems. In mixtures that do not fold (thick solid line), the order
parameter equilibrates within the ﬁrst 10 ns and remains relatively
ﬂat for the entire simulation. Mixtures that do fold exhibit a steep
drop in the order parameter (−SCD) resulting from the folding
process. As the fold grows, the number of lipids oriented parallel to
Fig. 3. Two lipid–peptide simulations where folding does not occur within 500 ns of
simulation under small negative surface tension. Monolayers containing (a) MUT11
and (b) MUT16 are shown at 500 ns.
Fig. 4. Carbon-deuterium order parameter (−SCD) versus time for three representative
systems. Inmixtures that do not fold (thick solid line),−SCD equilibrates within the ﬁrst
10 ns and remains relatively ﬂat for the entire simulation. Mixtures that fold exhibit a
steep drop in the order parameter either very quickly (thin solid line), or more slowly
(dotted line). The data are running averages over 10 data points with data points taken
every 0.2 ns.
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lipids oriented perpendicular to the monolayer interface (negative
SCD) simultaneously decreases. Because the time for initiation of
folding varies, some mixtures experience this steep drop in order
parameter very early (thin solid line), while others don't drop steeply
until more than 100 ns have passed (dotted line). Even before this
steep decline, the order parameter often declines gradually as
undulations form and increase in magnitude. Note that the ﬂuidiza-
tion of the monolayer results in increased undulations and a decrease
in order parameter (which would include undulatory effects).
Furthermore, factors that promote larger undulations will favor
folding.
In Fig. 5a, the average order parameter (−SCD) of the lipid C2 tail
beads is plotted versus the number of hydrophobic residues per
peptide present for all of the simulations containing 256 lipids
(squares) reported in Table 1 and the mutant-containing monolayers
(circles) reported in Table 2. From this ﬁgure, a transitional order
parameter−SCD* ∼0.331 can be identiﬁed above which the monolayer
resists folding and below which all monolayers fold. There is oneexception; ∼5:1 DPPC:PAmonolayers containing SP-C do not fold and
yet for this monolayer −SCDb−SCD* . However, a plot of order
parameter versus time for this system (not shown) reveals that the
order parameter increases gradually with time and when averaged
over the last 10 ns of the simulation (triangle) gives−SCDN−SCD* . The
simulations containingmutant peptides (circles) display a decrease in
order parameter with increasing peptide hydrophobicity, in support
of the hypothesis that a decrease in the number of hydrophobic
residues leads to less perturbation of the monolayer and eventually
the elimination of folding.
In Fig. 5b, the data from Fig. 5a is reproduced with each data point
labeled according to the lipid components of the corresponding
simulation and with the data points corresponding to the mutant
simulations removed for clarity. The order parameter for the pure
DPPC monolayers decreases on addition of SP-B1–25 (14 hydrophobic
side chains) and decreases even more on addition of SP-C (26
hydrophobic side chains) instead. The order parameter also drops on
addition of POPG for all pure lipid and lipid–peptide monolayers. The
addition of PA leads to an increase in order parameter for DPPC
monolayers containing SP-C, which is lessened if the SP-C is
depalmitoylated, and to a decrease in order parameter for monolayers
containing SP-B1–25. In contrast, if PA is neutralized, a substantial drop
in the order parameter is observed (compared to monolayers
containing anionic PA) both in monolayers containing SP-B1–25 and
in those containing SP-C.
In addition to these order parameters, which are averaged for all of
the C2 tail sites in the mixture, the average order parameters of the C2
tails sites of each individual component were also calculated (not
shown). In mixtures of DPPC and POPG, the order parameters for
POPG are slightly lower than those for DPPC. This is to be expected
because POPG contains an unsaturated chain (and a charged head-
group). In mixtures containing DPPC and PA, the PA tails exhibit a
slightly higher order parameter than do the DPPC molecules.
However, a substantial drop in the order parameter is observed for
PA if it is neutralized.
The larger systems, containing 1024 and 2304 lipids per
monolayer, also show folding when their order parameters are
below the same transitional value. For instance, 256 lipid 1:1 DPPC:
DPPG monolayers do not fold; however once the monolayer size is
Fig. 6. Decreasing the temperature affects the occurrence of folding. DPPC monolayers
containing 256 DPPC and 4 SP-B1–25 molecules each are shown at 308 K (a) and 303 K
(b), after 500 ns under small negative surface tension.
Fig. 5. The carbon-deuterium order parameters (−SCD) versus the number of
hydrophobic residues per peptides present. (a) The carbon-deuterium order parameter
(−SCD) of the lipid C2 tail beads for pure lipid and lipid–peptide monolayers that do
(open symbols) and do not (closed symbols) fold. Simulations containing mutants
(circles) are distinguished from the other mixtures (squares) for clarity. The data are
averages over the time from 10 to 20 ns. The error bars are standard deviations in the
average order parameter with respect to time. From these results, the transitional order
parameter (dotted line) above which the monolayer resists folding is identiﬁed. For
DPPC/PA monolayers containing SP-C the order parameter shifts (arrow) above the
transitional order parameter at later times (triangle). (b) Same as (a), except each data
point is labeled with the lipid components of the corresponding simulation and the
data points corresponding to the mutant simulations are removed for clarity. The label
“nopc” signiﬁes that the palmitoyl chains have been removed from SP-C, and the label
“neutral” signiﬁes that PA has been neutralized.
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accompanied by a shift in order parameter from above to below the
transitional order parameter. When 256-lipid monolayers of pure
DPPC are increased in size by factors of four and nine, no folding is
observed. In these cases, although the order parameter shifts slightly
downward with increasing system size, it remains well above the
transitional order parameter.
Both POPG and the surfactant peptides SP-B and SP-C ﬂuidize the
monolayer. However, unlike POPG, these peptides are not distributed
uniformly throughout the monolayer and therefore the order
parameter can be resolved locally. For monolayers containing 256
DPPC and 4 SP-C molecules per monolayer, the distance between the
C2A beads of DPPC and the closest SP-C bead was calculated for each
tail at 10 ns. The lipids were then binned into two categories based on
their distance from a peptide and the average order parameter for the
C2A tail sites was calculated for each category. Lipids with C2A beads
≤1 nm away are considered “neighboring” lipids, and those with C2A
sites N1 nm away are considered “distant” lipids. The order parameter
for the “neighboring” lipids (0.284±0.029) is smaller than theaverage order parameter over all C2A beads for the entire monolayer
between 10 and 20 ns (0.321). In contrast, “distant” lipids have an
average order parameter (0.345±0.008) that is essentially the same
as the average order parameter, for the C2A tail sites, obtained for the
pure DPPC monolayer (0.350). The standard errors given here were
approximated by using a binwidth of 0.10 nm to groupmolecules into
multiple data points within each category (neighboring and distant).
The lipid tail order of DPPC monolayers containing SP-B1–25 displays a
similar distance dependence. These results suggest that peptides
increase the monolayer ﬂuidity locally.
3.5. Temperature and surface tension
The folding exhibited at 323 K for pure lipid and lipid–protein
mixtures occurs in LE phase monolayers. As the temperature is
decreased the monolayers undergo a phase transition from LE to LC
phase that affects the folding transition. In Fig. 6, monolayers containing
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are shown after 500 ns of simulation under a small negative surface
tension. The transition from LE to LC occurs in these monolayers at
around 308 K. At 313 K themonolayers fold, just as seen at 323 K.When
the temperature is reduced to 308 K and 303 K peptide aggregation still
occurs; however changes in folding behavior are evident. As shown in
Fig. 6a, at 308 K folding occurs in only one monolayer (folding always
occurs concurrently inbothmonolayers at 323 K), resulting in shrinkage
of the lateral dimensionsof the simulationbox, thereby forcing the other
monolayer into the LC phase. At 303 K, both monolayers condense into
the LC phase (Fig. 6b). At both 303 K and 308 K, the peptides in the LC
phase monolayers are pushed further into the water subphase and no
folding occurs within 500 ns of simulation time. As the system size is
increased, themonolayers are able to fold at lower temperatures. For the
largest system size, DPPC monolayers containing SP-B1–25 fold at both
308 K and 303 K. At 303 K coexistence between LC and LE phase is
evident in the largest system; however undulations form and the
monolayers disorder leading to thedisappearanceof the LCphase before
folding occurs. To test whether folds and LC–LE coexistence could be
observed simultaneously, temperaturewas further lowered to 298 K. At
298 K LC–LE coexistence was evident; however the monolayer did not
fold within the simulation time, and a few of the SP-B1–25 molecules
were forced completely out of themonolayer and into the subphase. The
collapse of LC phase DPPCmonolayers has been previously simulated at
temperature of 300 K, using the MARTINI model [61]. This collapse
occurred by formation a small buckling deformation and required a
larger negative surface tension and system size than utilized in our
simulations.
When the surface tension is increased, the monolayers gain
stability against collapse. Larger systems (1024 or 2304 lipids) of
DPPC mixed with POPG, SP-B1–25, or SP-C with a small negative, zero,Fig. 7. A bicelle that has desorbed from one monolayer containing 256 DPPC molecules and
images are shown for clarity. This simulation was started with peptides initially in a line coand small positive surface tensions always yield order parameters that
are below the transitional order parameter identiﬁed above. However
folding is not always observed for these simulations with zero or small
positive surface tensions within the simulation time, because of
increased stability against collapse. Folding would likely occur if these
simulations were run for a long time.
As shown in Table 1, at the largest system size (2304 lipids per
monolayer) both 1:1 DPPC:POPG and DPPC monolayers containing 36
SP-B1–25 molecules fold under a small negative surface tension. If the
surface tension is set to zero, folding occurs readily in the SP-B1–25-
containing monolayer (within 100 ns), with a group of nearby
peptides (not a well deﬁned aggregate) acting as a nucleation site
for fold formation. However, 1:1 DPPC:POPG monolayers exhibit
small undulations but show no signs of folding, at this surface tension,
even after 450 ns of simulation time. As mentioned earlier, in the
smallest system size, it is also true that only peptide-containing
monolayers fold under a small negative surface tension. These results
indicate that the surfactant peptides play a signiﬁcant role in the
folding process and provide a larger driving force for folding than does
the unsaturated phospholipid POPG.
3.6. Bicelle formation, fusion, and re-expansion
As the folds continue to grow, eventually a bicelle desorbs, leaving
a monolayer surface behind (Fig. 7). When the folds from each
monolayer come close to one another, the peptides from each fold can
interact (Fig. 2b), leading to the fusion of the two folds into a lipid
bridge. The formation of this lipid bridge resulting from peptide–
peptide interaction demonstrates the fusogenic ability of the peptides.
To test the respreadability of the bilayer folds we imposed a
negative tangential pressure (positive surface tension) onto the4 mutant peptides (MUT2) after 275 ns under small negative surface tension. Periodic
nﬁguration.
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B1–25 or SP-C). When a tangential pressure of −5 bar is applied
(γ=25 mN/m), each system, with either SP-B1–25 or SP-C, quickly
(with 50 ns of simulation) respreads to form a monolayer. During re-
expansion the folds respread by the same experimental mechanism
described by Lee and coworkers [13,18], with the folds “unzipping”
back into the monolayer.
Setting the surface tension to 50 mN/m to re-expand the folds
after a lipid bridge had formed between the two monolayers
(Fig. 8a), results in the reincorporation of more peptides into one
monolayer than the other (Fig. 8b). Since the initial formation of the
lipid bridge resulted from peptide–peptide interactions, this process
can be thought of as the peptide-mediated transfer of surface-active
material between interfaces. The formation of a lipid bridge by
peptide-mediated fusion and the ensuing peptide redistribution
upon re-expansion demonstrate the fusogenic abilities of the
peptides and their role in surface reﬁning.Fig. 8. An example of peptide-mediated surface reﬁning. (a) A lipid bridge has formed bet
molecules each. (b) After the lipid bridge is re-expanded, there are more peptides incorpor4. Discussion
4.1. Folding mechanism
The mechanism of collapse depends on the phase morphology,
which is determined by temperature, surface pressure, composition,
and compression rate. The collapse of highly compressed monolayers
can occur by a variety of mechanisms including folding, crystallite
formation, and nanoscale budding [19]. Factors that favor more ﬂuid
structures, such as higher temperature, promote collapse by forming
discs, multilayers, or vesicles [19,93]. For example, Gopal and Lee [93]
showed that for a 7:3 DPPC/POPG monolayer at low temperatures
(below 28 °C) the monolayer is biphasic and collapses by forming
reversible large-scale folds (up to millimeters in length), while at high
temperatures (above 33.5 °C) the monolayer is homogenous and
collapses by forming micron-scale vesicular structures, and at
intermediate temperatures (28–33.5 °C) collapse occurs by formingween two monolayers originally containing 256 DPPC and 4 mutant peptide (MUT1)
ated into one monolayer than the other. Periodic images are shown for clarity.
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disordered phase increases and the ﬂuidity therefore also increases,
resulting in a monolayer that collapses on a smaller length scale by
forming vesicle-like structures. Faster compression rates favor
smaller, more numerous, collapse structures [94]. Reduced compres-
sion rate lead to a slightly increased disc size in collapsed calf lung
surfactant extract (CLSE) ﬁlms [19].
SP-B is known to promote the transition from 2D to 3D structures
such as small independently nucleated collapse struc-
tures [4,12,14,16,18,20–22] and macroscopic folds [13,15,18,49]. SP-
B1–25 [12–16] and dimerized SP-B1–25 [16,20] have also been found to
induce these transitions in phospholipid monolayers. SP-C also
promotes the formation of collapse structures. While SP-B is
associated with the formation of small disc-like protrusions, SP-C is
associated with sheets of bilayers stacked on top of each other
[4,15,18,21–27,29–31]. SP-B, SP-B1–25 and SP-C are excluded from the
condensed phase and localize within the ﬂuid phase [12–15,18,21–
25,27,28,95,96]. Therefore, small disc-like protrusions and multilayer
stacks [4,15,18,21–24,27] have been reported to originate from the
expanded phase regions, as observed in our simulations of folding of
liquid-expanded phase monolayers. These small collapse structures
are sometimes called surface aggregates. Also, the term “squeeze-out”
is sometimes used to describe the formation of these collapse
structures. However, the “squeeze-out” of these collapse structures
does not necessarily imply that the surface is reﬁned to contain almost
pure DPPC, as held by classical squeeze-out theory.
Another type of collapse structure, macroscopic folds, has also
been reported for model surfactant mixtures. Lee and coworkers
[13,15,18,49] found that ﬁlms containing SP-B in DPPG, DPPG/POPG,
or in DPPC/POPG/PA as well as pure lipid ﬁlms consisting of DPPG/
POPG or DPPC/POPG/PA exhibited a ﬂat monolayer coexisting with a
buckled monolayer, rendering collapse reversible and enabling rapid
respreading upon expansion. The folds consisted of coexisting LC–LE
domains that extended several microns into the subphase, and had
the same average composition and morphology as the monolayer
[13,15,18,49]. Lee and coworkers [13,18,49] suggest that coexistence
of LC and LE phases is an essential feature required for reversible
collapse via the macroscopic folding transition. They propose that the
coexistence of LC and LE phases provides the monolayer enough
ﬂexibility to bend and enough cohesiveness to prevent loss of material
to the subphase.
Both types of collapse structures—discs or multilayers and
macroscopic folds—are reversible. Macroscopic folds are ∼100 µm–
1 mm in length and extend several µm into the subphase. Bilayer discs
are typically b10–500 nm in diameter with a height corresponding
roughly to the thickness of a single bilayer. Multilayers are typically
b0.1–10 µm in size with discrete steps in heights corresponding to
roughly to the thickness of a bilayer (5–7 nm). The formation of
partial collapse structures (disc-like protrusions or multilayers)
occurs at ∼40–45 mN/m [16,18,21,22] in SP-B containing monolayers
and at ∼50–55 mN/m [18,21–24,26,27,29–31] in SP-C containing
monolayers, near the equilibrium spreading pressure (πe) of ∼45–
50 mN/m [4]. After partial collapse occurs, the surface pressures
continue to increase upon further compression as shown by the
isotherms reported in several studies [4,15,16,18,20,23,24,30]. In
contrast, the formation of macroscopic folds occurs at higher surface
pressures of ∼60–70 mN/m [13,15,18,49] and corresponds to large-
scale collapse at the collapse pressure (πc). The surface pressure does
not increase any further after the folds have formed, but remains
constant [13,18,49].
Electronmicrographs of thin sections of rabbit lungs have revealed
that portions of the alveolar ﬁlm are multilamellar [11]. Multilamellar
ﬁlms can form not only by collapse but also by adsorption [97,98].
Reversible discs and/or multilayers have been identiﬁed in BLES
(bovine lipid extract surfactant) [4,17] and CLSE [19]. There is also
experimental evidence for the formation of multilayers during BLESadsorption [99]. It has been suggested that the extended irregularly
shaped multilayers identiﬁed in BLES may have originated from
multiple folding events and/or the fusion of smaller stacks [17].
Likewise, the formation of stacked discs, overlapping discs, and chains
of attached or fused discs has been observed in ﬁlms containing CLSE
[19]. To the best of our knowledge, there is no evidence of
macroscopic folds in surfactant extracts without added PA. However,
the lung surfactant Survanta, which contains a signiﬁcant portion of
PA (8.5% w/w), displays a rich variety of collapse structures, including
reversible macroscopic folds that maintain the same morphology as
the monolayer [15,28], larger multilayers (800 µm wide) [28], and
smaller lipid–protein aggregates [20,28]. It has been suggested that
the collapse of Survanta could occur by a complex mechanism
involving the detachment of the buckled region followed by
reattachment to form more complex multilayered structures [28].
However, experiments involving the injection of BLES underneath
pre-formed ﬁlms of either BLES or DPPC suggest that reattachment to
a monolayer at equilibrium does not occur readily [99].
The “folds” observed in our simulations occur in LE phase
monolayers, and our simulation box size is smaller than the size of a
single experimental LE phase domain. Therefore, the “folds” observed
in our simulations are similar to the small collapse structures
originating from the protein rich LE phase rather than macroscopic
folds. Still, even the “small” collapse structures seen experimentally
(∼35 nm, Ref. [16]) are larger than our folds, and so direct
comparisons of our simulated collapse structures to the experimental
ones must be made with caution.
Our simulations do suggest, however, that folding can occur
through the ampliﬁcation of undulations (buckling). We ﬁnd that
folding can also occur by nucleation of a fold about a defect, whichwill
be addressed later in this discussion. Folding by ampliﬁcation of
undulations has been observed previously by CG molecular dynamics
[62] and is in agreement with experimental observations and the
general wrinkle-to-fold transition mechanism described previously
by Lee and coworkers [100,101]. According to Lee and coworkers
when a membrane undergoes compression the amplitudes of the
undulations grow until a critical compression is reached, at which
instability leads to rapid ampliﬁcation of one or a few wrinkles, while
the rest decay to zero [100,101]. However, as noted previously, our
folds are on a much smaller length scale than the macroscopic folds
reported by Lee and coworkers which span across both LC and LE
phase domains and maintain the original biphasic morphology of the
monolayer.
Small (nm scale) globular structures have been identiﬁed in model
surfactant mixtures at low surface pressures and are thought to be
nucleation sites for subsequent multilayer formation [21,22,29]. Small
nuclei have also been identiﬁed in CLSE ﬁlms, which grow into larger
collapse structures [19]. The folds observed in our simulations could
be similar to these pre-collapse nuclei.
Variations in the composition of the monolayer can lead to
variations in spontaneous curvature and bending modulus between
domains [50]. It has been suggested that as the monolayer is
compressed the curvature at domain boundaries can grow, causing
the monolayer to overlap itself, resulting in the formation of a
multilayer [50]. Due to the ﬁnite system size, ﬁnite simulation time,
and the absence of domains of varying heights in our simulations we
do not observe monolayer overlap, or the formation of multilayers.
Instead we observe folds extending into the subphase.
Visualization of collapse structures commonly requires deposition of
the ﬁlm onto a substrate, which could result in ambiguities about the
actual shape and orientation of experimental collapse structures. In the
past there has been some ambiguity about whether aggregates collapse
into the subphase or into the air. All folds observed in our simulations
occurred into the water subphase. This is in agreement with the
observations of Baoukina et al. [63],which suggest that buckling into the
water subphase is more favorable because it results in a lower free
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although a lipid bilayer patch in the water subphase is stable, an
inverted bilayer patch placed in the vacuum subphase is unstable and
readily fuses with the adjacent monolayer [63]. Although these results
suggest that collapseoccurs into thewater subphase rather than into the
air, we cannot discount the fact that the simulation conditions differ
somewhat from physiological conditions.
4.2. Component effects
Fluidizing agents promote collapse by decreasing the bending
rigidity of the monolayer and increasing themobility of the constituent
lipids. The decrease in bilayer bending modulus with increasing
unsaturated lipid content has been demonstrated previously [62]. Our
results indicate that the addition of ﬂuidizing agents such as POPG, SP-B
and SP-C assist collapse out of the LE phase, which occurs experimen-
tally through the formation of surface aggregates near πe. Conversely,
condensing agents resist this collapse, providing access to higher surface
pressures where collapse may occur by a different mechanism. We
propose that the proteins further assist collapse by acting as defects in
the monolayer about which collapse structures can nucleate. The
peptides appear to provide a larger driving force for folding than the
unsaturated phospholipid POPG, allowing fold formation to occur for
peptides containing monolayers under conditions for which it does not
occur in the presence of POPG alone. The extent of the perturbation of
the peptide-containing monolayers (and the occurrence of folding) is
determined by the hydrophobicity of the proteins.
4.2.1. Pure DPPC
DPPC is relatively incompressible, but will eventual collapse once
overcompressed [102]. LC monolayers of DPPC have been reported to
form highly condensed multilayered collapse structures [103,104], and
nanometer scale folds [102]. However, unlike the discs or multilayer
structures formed in the presence of peptides, these collapse structure
formed out of the condensed phase and were irreversible. Once the
temperaturewas raised above themain transition temperature of DPPC
these collapse structures no longer formed [102,103]. Other studies
have reported that collapse of highly compressed DPPC occurs by
reversible nanoscale budding into the air [105]. Yang and Tsay [104]
reported irreversible multilayer structures and reversible structures.
However, the reversible structures were considered to be elastic
deformations rather than true collapse structures.
4.2.2. Unsaturated lipids
In agreement with our observations, the ﬂuidizing effect of POPG
on LE phase DPPC molecules has been detected by vibrational sum
frequency generation spectroscopy [89]. Additionally, the ability of
the unsaturated lipids to form curved structures (because of their
ﬂuidity) and preferential interaction between SP-B and the charged
headgroup of POPG are thought to promote the formation of
multilayered structures [16].
4.2.3. Surfactant proteins
SP-C [21,22,95], SP-B [12–14,21,22,95,96], and SP-B1–25 [12–14]
have been found to perturb monolayers of DPPC, DPPC/DPPG, and PA,
increasing the overall ﬂuidity of the monolayers and producing
smaller and more numerous condensed phase domains with a lower
line tension between the condensed and expanded phases. Increasing
the amount of protein increases the amount of ﬂuid LE phase
[12,14,21,95,96]. SP-B and SP-C also perturb the molecular packing
of the ﬂuid phase in which they are distributed [95].
On a per molecule basis, SP-B ﬂuidizes the lipid monolayer more
than does SP-C [21,22,95], but the reverse is true on a per unit mass
basis [95]. Therefore the more pronounced ﬂuidization of the
monolayer by SP-B could be due in part to the size difference between
the two peptides. We observe that SP-C contains more hydrophobicresidues and displays a stronger ﬂuidizing effect than the fragment
SP-B1–25, causing a larger drop in the carbon-deuterium order
parameter. In addition, we observe that the peptides have a localized
effect on order. This is in agreement with atomistic simulations
[56,57], which have shown that SP-B1–25 signiﬁcantly decreases the
order of nearby fatty acids in a PA monolayer, and less disordering of
fatty acids further away. Since the ﬂuidization of the monolayer is
localized, and ﬂuidity promotes collapse, this could result in a higher
propensity for collapse in the immediate vicinity of the peptides.
The ability of the peptides to promote collapse in our simulations is
in agreement with observations that hydrophobic proteins slightly
speed up collapse in monolayers containing the complete set of
surfactant lipids at 37 °C [48] and in contrast to studies where the
proteins were reported to stabilize monolayers against collapse [12–
14,18]. Lee and coworkers [12,14,49] suggest that SP-B or SP-B1–25 has
a synergistic effect with components such as PA and POPG (that have
low πc values), which allows the attainment of high surface pressures
(above the πc values of either component) in lipid–peptide mono-
layers. However, this stabilization is not expected in DPPC mono-
layers, since DPPC is on its own capable of sustaining near-zero
surface tension (high πc). We observed no obvious synergy between
POPG and SP-B1–25 in our 1:1 DPPC:POPGmonolayers. Both 1:1 DPPC:
POPG monolayers containing SP-B1–25 and DPPC monolayers contain-
ing SP-B1–25 collapse readily, with the former displaying a lower order
parameter suggesting only an additive effect of POPG and SP-B1–25 on
monolayer ﬂuidity. However, the existence of a synergistic effect
cannot be ruled out, especially given the length and time scale of our
simulations.
It has been recently proposed that surfactant proteins diminish the
activation energy barrier to collapse, increasing the rate of collapse
above πe ,[48,106]. The proteins could act as a catalyst, promoting
reorganization at the interface and lipid exchange between surfactant
storages and the interfacial ﬁlm [48,106]. Our results also support this
conclusion by showing the ability of surfactant peptides to promote
collapse and fusion.
We found that in DPPC/SP-C/PA monolayers, collapse did not
occur; however collapse occurred in both DPPC/SP-B1–25/PA and
DPPC/depalmitoylated SP-C/PA. These observations are in good
agreement with experiments, which show that SP-C palmitoylation
dramatically increases ﬁlm stability [107]. Qanbar et al. [107] found
that ﬁlms containing depalmitoylated SP-C or SP-B were much more
prone to instability than ﬁlms containing SP-C. Furthermore, SP-B is
removed from the interface at lower surface pressures than is SP-C as
is evident from plateaus in the isotherms of model surfactant mixtures
containing these proteins; this has been reported by Nag et al. [95]
and many others. Depalmitoylation of SP-C is also thought to impede
the formation of multilayers and hinder respreading and adsorption
[26,107].
4.2.4. Palmitic acid
In contrast with unsaturated lipids and surfactant proteins, and in
agreement with experiments, we ﬁnd that PA provides stability
against collapse of the LE phase. These results suggest that condensing
agents such as PA could act to restrict the formation of the small disc
or lamellar collapse structures occurring out of LE phase domains just
above πe. PA is used as an additive in surfactant replacements to
enhance monolayer stability and is thought to have effects similar to
those of increasing the surface pressure or decreasing the tempera-
ture of DPPC-containing monolayers [50,108]. It is well documented
that PA condenses DPPC-containing monolayers by increasing the
conformational order of the DPPC tail chains in the LE phase [89],
increasing the fraction of LC phase, decreasing the tilt of LC phase
DPPC molecules, and increasing the rigidity of the monolayer
especially at low surface tensions [15,108].
Atomistic molecular dynamics simulations of SP-B1–25 in PA
monolayers suggest that strong electrostatic interactions between
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groups of PA anchor the peptide to the monolayer [56,57] and could
provide stability to the ﬂuid PA/SP-B1–25 regions of the monolayer
[57]. This is in good agreement with the increased resistance to
collapse observed in our simulated monolayers containing DPPC with
SP-C upon the addition of PA and with experimental observations.
However, the increase in order parameter observed upon addition of
PA to DPPC monolayers containing SP-C was absent in DPPC
monolayers containing SP-B1–25; instead a decrease was observed.
Lee and coworkers have proposed that in order for reversible
macroscopic folding to form the monolayer must be within “the
Goldilockwindowof rigidity”; neither too rigid nor too ﬂuid [49]. They
found that addition of components that rigidify themonolayer, such as
PA, promotes the formation of macroscopic folds, and factors that
ﬂuidize the monolayer, such as the addition of monovalent ions to the
subphase, or an increase in temperature, lead to the disappearance of
the macroscopic folds [15,49,93]. Our observations are in agreement
with the observations of Lee and coworkers and suggest that the
addition of a condensing agent could restrict the formation of small-
scale LE phase collapse structures leading to large-scale collapse at
higher surface pressures. We also ﬁnd that when PA is neutralized a
substantial drop in order parameter is observed and the condensing
effect of PA on DPPC monolayers containing SP-C, is eliminated.
4.3. Defects and aggregation
For large systems under a small negative surface tension, folding
usually proceeded through ampliﬁcation of the undulations, while for
smaller systems, a defect was always required, about which a fold
could nucleate. To test whether fold nucleation about a peptide defect
could be reproduced for the largest system size, we replaced four of
the peptides in the 2304 DPPC and 32 SP-B1–25 monolayers with a pre-
formed peptide aggregate, after 0 ns and 20 ns of simulation
(Supplementary material), under small negative surface tension. For
both times we got the same result: fold nucleation about a defect
occurred in one of the monolayers and the other monolayer folded by
ampliﬁcation of undulations. Additionally, when monolayers contain-
ing 2304 DPPC and 32 SP-B1–25 molecules were simulated with
surface tension set to zero, fold nucleation around a group of peptides
was evident. These results suggest that folding by nucleation about a
defect is not conﬁned to small systems only.
It has been previously proposed that variations or defects in the
monolayer could act as nucleation sites for collapse. For instance,
small height differences existing at domain boundaries between
coexisting condensed and expanded phase domains have been
suggested as nucleation sites for the formation of macroscopic folds
[13,93,109]. Packing defects have also been suggested as inducers of
pre-collapse instabilities [26,105]. The surfactant proteins could act as
impurities or defects in the monolayer, which lower the activation
barrier for collapse. Hydrophobic surfactant proteins have been
proposed to have a destabilizing effect on monolayers that assists
collapse [48,106]. SP-C mutants containing only 13 residues (with
smaller α-helices) were also reported to act as defects in the
monolayer, which were squeezed out of the monolayer instead of
more tightly packed lipids [26].
The behaviors of the surfactant peptides and their roles as nuclei in
the folding process observed in our simulations are in broad agreement
with inferences from several other experimental observations. Serrano
and Pérez-Gil [110] suggest that SP-B associates preferentially at the
monolayer interface, binding to surfactant lipids with high afﬁnity,
inducing perturbations in packing, and promoting the transfer of lipids
between the interfacialﬁlmandadjacent bilayers. Krol et al. [21] suggest
that SP-B localizes at the edge of bilayer protrusions, reducing line
tension and functioning like a zipper, enabling disc-like bilayers to
squeeze-out of the monolayer and respread rapidly during the
breathing cycle.It has been suggested that SP-B could undergo some combination of
conformational, orientational, or aggregational change induced by
compression to high surface pressures [12,14]. After observing the
formation of SP-B clusters at domain boundaries in DPPC ﬁlms, Cruz et
al. [96] suggested that aggregation could occur after the solubility limit
of the peptide in the lipid monolayer is reached. Experiments have also
shown that aggregation of SP-B in phospholipid membranes leads to
membrane destabilization [111], and when present at high concentra-
tion, SP-B perturbs DPPC bilayers and induces large amplitude lipid
reorientation, likely leading to signiﬁcant bilayer curvature [76].
We propose that the size of the protein affects its surface activity
and that the aggregation of SP-B1–25 could be a mechanism for
replicating the activity of the full-length protein. Experimentally, SP-
B1–25 can mimic the effects of the full-length protein, but only at
higher concentrations. SP-B exists as a homodimer, which increases
the contact area available for interaction with lipids in the monolayer
and associated reservoir. One can envision how the aggregation of SP-
B1–25 could lead to the formation of a cluster of peptides with
positively charged regions facing outward toward the water subphase
and hydrophobic regions facing in, available for lipid interaction. In
fact, experimental studies have shown that fragments of SP-B show
decreased fusogenic, lytic, and surface tension-lowering abilities
relative to the full-length SP-B, but that these properties are improved
when the fragments are present at higher concentrations [112,113].
Another important study suggested that homodimerization of SP-B is
primarily related to surface tension reduction [114]. In this study, SP-B
monomer restored surfactant function in SP-B deﬁcient mice, but was
not as effective as dimerized SP-B at surface tension reduction.
However, a 2-fold (four times the molar quantity of dimeric SP-B)
increase in SP-B monomer resulted in a surface tension reduction
similar to that produced by dimeric SP-B.
The peptide aggregation observed in our simulations occurred for
SP-B1–25, SP-C, and all mutant peptides tested, suggesting that the
observed aggregation does not result from speciﬁc protein–protein
interactions. Furthermore, peptide aggregation occurred in mono-
layers containing a single phase and a single lipid component,
suggesting that the observed aggregation is not due to phase
separation or speciﬁc lipid–peptide interactions. Instead the observed
aggregation occurred by a lipid-mediated mechanism. These local
lipid-mediated interactions hold the peptides together in a fold-
inducing aggregate, analogous to the way local interactions hold
peptides together to form a pore. The undulatory modes of the
monolayer, which produce curvature in the surface, act as sinks for
monolayer impurities. Our observations are in agreement with a
universal mode of curvature-induced aggregation proposed by
Reynwar et al. [115]. Utilizing CG-MD simulations, Reynwar et al.
[115] modeled curvature-inducing proteins as caps in a bilayer
membrane, with a hydrophilic attraction to the lipid headgroups of
the bilayer, but no attraction to other caps. The overlap of the bilayer
deformations formed by curvature-inducing proteins leads to an
indirect attractive force between the proteins, since overlap helps to
minimize the elastic energy of the membrane. This attraction results
in aggregation of the caps and subsequent vesiculation of the cap rich
region. The peptides in our simulations are relatively small and are not
associated with sizeable curvature induction; however the undula-
tions that arise from the compression of the monolayer provide
substantial curvature to drive the aggregation of peptides.
4.4. Mutants
Pérez-Gil and coworkers [110,113] used synthetic peptides to map
the fusogenic and lytic domains of SP-B and determine how these
fusogenic and lytic capabilities inﬂuence surface activity. They
determined that the N-terminal half of the protein (residues 1–37)
was mostly responsible for the fusogenic, lytic and surface-active
properties of the full-length protein, with helix 1 (residues 7–22)
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[110,113]. Moreover, amino acid substitutions that impaired fuso-
genic or lytic activities of SP-B also impaired surface tension
reduction, which suggests that SP-B fusion and lysis likely play an
important role in the formation and maintenance of the alveolar
surface ﬁlm [113].
Pérez-Gil and coworkers further concluded that the N-terminal tail
(residues 1–9) is required to insert into and perturb compressed
interfacial ﬁlms [110,113] and appears to have a crucial role in surface
tension reduction [113]. An amino acid substitution of alanines for
prolines at positions 2, 4, and 6 (resulting in the extension of helix 1
and elimination of the tail motif, but no signiﬁcant change in
hydrophobicity) restricts the ability of the peptide to perturb the
packing in the interfacial ﬁlm and promote lipid insertion [110].
Paired substitution of hydrophobic residues on the non-polar face of
helix 1 or substitution of multiple positively charged residues leads to
an increase in minimum surface tension [113]. In accord with these
results, atomistic molecular dynamics simulations have suggested
that the N-terminal tail motif is important for anchoring SP-B1–25 to
the monolayer and charged amino acids are important for positioning
the peptide in themonolayer [54]. The highly hydrophobic N-terminal
tail motif of SP-B is also well conserved across species [3].
The results of our mutant peptide simulations can be compared
with those of Pérez-Gil and coworkers only qualitatively. In the
MARTINI model, the secondary structure of the peptides is held ﬁxed
by the angle and dihedral potentials, so any change in the secondary
structure of the peptides is not captured. Although the secondary
structure is not altered in our simulations, removal of the highly
hydrophobic insertion sequence has a similar effect as the substitu-
tions made by Pérez-Gil and coworkers to the N-terminal tail motif,
namely it causes the peptides to penetrate less deeply into in the
monolayer resulting in less perturbation. In general, we ﬁnd that
altering the hydrophobicity of the peptides affects the perturbation of
the monolayer and thus the propensity for collapse.
4.5. Squeeze-out and supercompression
At pressures above πe, the disordered LE phase collapses at rates
that are ﬁnite, in contrast to condensed phases that have been shown
to sustain surface pressures well above πe [45]. At physiological
temperature (37 °C) DPPC is the only component that can form a
condensed phase at surface pressures below πe [45]. This observation
led to classical squeeze-out theory, which holds that in order to reach
a near-zero surface tension the monolayer must be reﬁned by the
selective squeeze-out of non-DPPC components from the interface,
leaving behind a monolayer that is highly enriched in DPPC.
There are recent experimental ﬁndings that suggest that the
collapse structures formed from model surfactant mixtures are
enriched in non-DPPC components. However, enrichment does not
necessarily imply that the monolayer left behind is almost pure DPPC
as held by classical squeeze-out theory. Mao et al. [116] studied the
collapse of perdeuterated DPPC (DPPC-d62)/DPPG/SP-C/cholesterol
ﬁlms at 20 °C. They determined that all three components with
identiﬁable IR signatures (DPPC-d62, DPPG, and SP-C) were present in
the multilayers, but ﬂuorescence and IR data suggested that both SP-C
and DPPG were enriched in the multilayer phase [116]. Several other
experimental studies have reported protein enrichment in collapse
structures, in model surfactant mixtures containing SP-B or SP-C [21–
24,27,30]. Additionally, the atomistic simulations of Rose et al.
[58] show that the addition of unsaturated phospholipids inﬂuences
the response of DPPCmonolayers to compression, resulting in some of
the unsaturated lipids begin ejected from or partially forced out of the
monolayer. Rose et al. suggest that this constitutes evidence for the
selective squeeze-out of POPG. However, they admit that their
simulations are limited both by system size and simulation time,
which could affect the observed collapse behavior. In contrast, someexperimental studies report little or no difference in composition
between the monolayer and the collapse phase. For example, Yu and
Possmayer [43] found no signiﬁcant differences in lipid composition
between the multilayer and the adsorbed interfacial monolayer, in
ﬁlms spread from dispersions containing BLES. Additionally, the CG-
MD molecular simulations of folds formed in DPPC/POPG [62] and
DPPC/POPG/cholesterol/SP-C [63] monolayers show no signiﬁcant
differences in lipid or protein composition between the monolayer
and the collapse phase.
It has been suggested that since the monolayer ﬂows continuously
into the collapsed phase, the collapse structure should have the same
composition as the phase from which it is formed [19]. The
coexistence of DPPC-rich LC phase and non-DPPC rich LE phase
could therefore lead to enrichment of collapse structure (formed from
the LE phase) in non-DPPC components. However, in extracted
surfactant at 37 °C the LC phase occupies only 4–6% of the interface
when collapse from the LE phase begins [47]. Therefore compositional
reﬁnement by selective exclusion is thought to be limited [19].
Moreover, to attain a ﬁlm of only LC phase would require an
unphysiologically large area reduction [47,51], providing a strong
argument against classical squeeze-out.
An alternate hypothesis to explain the ability of lung surfactant to
maintain stability at near-zero surface tensions has been proposed by
Hall and coworkers. According to this hypothesis, when compressed
quickly enough, ﬂuid monolayers can transform into metastable ﬁlms
capable of maintaining high surface pressures. This supercompression
likely results in amorphous solids that exhibit resistance to ﬂow
([45,47,51], and references therein). Supercompression has been
demonstrated in CLSE and in monolayers composed entirely of the
unsaturated phospholipid POPC, verifying that the observed metasta-
bility does not result from a change in composition [45]. As collapse
occurs material is removed from the interface thereby lowering the
surface pressure; therefore to attain high surface pressures the
monolayer must be compressed faster than the rate of collapse
[47,51]. Although the compression rate during normal breathing
exceeds the rate required for supercompression, in excised lungs
much slower compressions produce functional ﬁlms [47,51]. This
stability is unexplained by supercompression.
In agreement with recent experimental [43] and CG-MD simula-
tion [62,63] results suggesting no differences in lipid composition
between the monolayer and surfactant reservoir, no signiﬁcant
differences in lipid composition between the monolayer and fold
are observed in our collapsed LE phase monolayers. Our simulations
do however suggest that the collapse structures can be enriched in
surfactant peptides, when folding occurs by nucleation around a
peptide aggregate. Our simulations do not display any evidence of
supercompression.
4.6. Reversibility and bicelle formation
Our results suggest that the peptides promote the formation of the
collapse phase, and show that the folds can be reversibly reincorpo-
rated upon expansion, if the connectivity between the fold and the
monolayer remains. Our simulations provide no evidence suggesting
that the peptides are required to provide reversibility. Lung surfactant
proteins SP-B and SP-C could, however, have an anchoring effect,
which would attach the collapse phase to the monolayer interface
providing reversibility. In one of our DPPC monolayers containing SP-
C, with the α-helix of the SP-C molecules placed initially embedded in
the tail region, we do observe the anchoring of a bicelle fold to the
interface by a SP-C aggregate that remains partially embedded in the
monolayer interface (Supplementary material).
It has been suggested that SP-C stabilizes the collapse structures by
anchoring the multilayer collapse structure to the surface monolayer,
with its palmitoyl chains inserted into one layer and its α-helix
inserted into the adjacent layer [17,23–27,29]. It has also been
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interface at high surface pressures, facilitating lipid transfer to and
from the interface [110,112,113]. Additionally, ﬁlms containing dSP-
B1–25 exhibit better respreadability than ﬁlms containing SP-B1–25,
possibly because dimerization in native SP-B or in dSP-B1–25 could
maintain the lipid reservoir by creating a bridge with one monomer
attached the reservoir and the other attached to the interface [112].
The role of SP-B in maintaining the collapse structure could be similar
to the proposed role of SP-B in the crosslinking of vesicles [117], in
which charged regions of SP-B interact with the headgroups of the
two vesicles and the central parts of SP-B present a non-polar surface
across which lipid transfer occurs.
The molecular dynamics simulations of Baoukina et al. [62], which
used the MARTINI CG model to simulate 4:1 and 1:1 DPPC:POPG
monolayers, report the transformation of the folds into “ﬂat circular
bilayers” and in some cases into vesicles. The fold-to-vesicle transition
was favorable for larger and softer aggregates (having a lower
bending modulus) and was driven by the line tension at the edge of
the bilayer fold. Low line tension (resulting in a longer monolayer–
bilayer connection) at themonolayer-fold junction is important to the
reversibility of collapse, because the line tension regulates the
connectivity, which is necessary for the transfer of lipids to and
from the collapse structure [62]. Our folds take on the shape of ﬂat
circular bilayers, but we did not observe vesicle or semi-vesicle
formation as seen in the simulations of Baoukina et al. [62], which
employed constant interfacial area to investigate the evolution of the
collapse structures. Instead, our simulations employ continuous
compression, under which the folds continue to grow and the
connection between the folds and the monolayer is reduced, making
the folds more circular in shape, and at last, in most cases, they desorb
from the monolayers, becoming bicelles.
4.7. Fusion and surface reﬁning
The fusogenic and lytic properties of SP-B may be important to a
number of processes occurring within the lung surfactant life cycle
including the transfer of lipids to and from the interface, processing of
the SP-C proprotein in the multivesicular body, the organization of
lamellar bodies, and the formation of tubular myelin [110,112,113]. In
our simulations, the ability of the surfactant peptides to destabilize
(especially after aggregation) the monolayer, promoting collapse,
reﬂects the lytic capabilities of the peptides. We further observed the
interaction of peptides (SP-B1–25 and mutant) from two separate
monolayer folds, leading to the fusion of the folds and the formation of
a lipid bridge. Ultimately this process was observed to result in surface
reﬁning (a change in the interfacial composition by the addition and/
or removal of surfactant material to or from the interface). The
observed peptide-mediated fusion is in good agreement with recent
experimental ﬁndings [106] that suggest protein–protein interactions
could be important to facilitate membrane–membrane apposition
during fusion. Several experimental studies [118–121] have proposed
that the ability of surfactant proteins to promote adsorption may be
attributed to the ﬂuidization of the monolayer and the destabilization
of the adsorbing vesicles by the surfactant proteins. The proteins may
also act as docking sites [118] or stabilize a structural intermediate
formed during the adsorption process [120]. However, a systematic
study of fusion and adsorption is beyond the scope of this work and
would require a different set up allowing for more consistency
between simulations (the fusion between folds seen here can only
occur if the folds from each monolayer come close to each other).
4.8. Effects of system size and time scale
When comparing simulation results to experimental or physio-
logical systems, it is important to take account of the limits of the
simulations, which could lead to artifacts or inherent differences inbehavior between the simulated membranes and their experimental
counterparts.
Due to the use of periodic boundary conditions, imposing a small
box size leads to artiﬁcial membrane rigidity and suppressed
undulations [60,70,71,122–124]. Previous coarse-grained molecular
dynamics simulations of DPPC monolayers have shown a decrease in
area compressibility modulus (i.e., an increase in compressibility) as
system size is increased, due to the ability of the larger system to
“wrinkle” or undulate [71,72]. Both CG and atomistic simulations of
lipid monolayers or bilayers yield compressibility moduli that are
signiﬁcantly larger than experimental estimates [62,71,72,125].
Applying a surface tension will also decrease undulations and thereby
reduce the undulatory contribution to the compressibility and the
magnitude of ﬁnite-size effects [123]. Size differences between our
simulated folds and experimental collapse structures could result in
differences in line tension at the monolayer-fold connection (λc) and
at the fold perimeter. The experimental line tensions at the edge of a
bilayer fold are smaller than those calculated from a CG bilayer slab in
water (5–30 pN versus 50 pN) [62]. As the ﬂuidity of the monolayer is
increased, the line tension at the monolayer-fold connection (λc) is
decreased, favoring the formation of collapse structures. For instance,
an increase in unsaturated phospholipids decreases the energetic
penalty for lipid deformations at the monolayer-fold parameter and
results in a decrease in λc [62]. Imposing a small box size leads to
artiﬁcial membrane rigidity, and therefore increases λc. To the best of
our knowledge no experimental values of λc are available for
comparison. Additional considerations also complicate comparison;
identiﬁed experimental collapse structures are larger than simulated
folds, can form more complex multilayered structures and peptide
anchors may lower the line tension at the monolayer–collapse phase
interface.
The system size affects the magnitude of the energy barrier that
must be overcome for buckling to occur [63]. The system size
restriction also affects collapse by reducing the probability of
monolayer defects. Although 1:1 DPPC:POPG monolayers do not
exhibit folding at the smallest system size simulated, even under a
small negative surface tension, when we increase the system size by a
factor of 4 or 9, folding is observed. In contrast, the pure DPPC
monolayers do not display folding even at the largest system size and
lowest surface tension tested. By decreasing the surface tension,
simulated monolayers can be induced to buckle, but this occurs at
lower surface tensions than for real monolayers due to the smaller
system size [62]. In agreementwith the observations of Baoukina et al.
[62], our simulations display an increase in undulations with
decreasing surface tension, with buckling occurring at negative or
near-zero surface tensions, for all system sizes studied.
Simulated compression occurs much faster than experimental
compression rates. Previous simulations [62] utilized intermittent
compressions separated by constant area simulations, performed at
selected surface densities, to allow time for equilibration. However,
the results of these simulations differ from those of our constant-
pressure simulations only in that in the former, vesicles form when
the compression is halted and the interfacial area is held ﬁxed.
Although an increase in compression rate was associated with larger
buckling amplitudes and lower surface tensions obtained before
folding, the collapse pathway was independent of compression rate
and method [62]. However, the compression rate is likely to affect
whether folding occurs by ampliﬁcation of undulations or by
nucleation about a defect.
4.9. Summary
Utilizing coarse-grained molecular dynamics simulations of model
surfactant mixtures, we have identiﬁed two mechanisms by which
monolayer folding can occur, namely [1] through the growth of
undulations and [2] by nucleation around a defect. The occurrence of
1648 S.L. Duncan, R.G. Larson / Biochimica et Biophysica Acta 1798 (2010) 1632–1650folding depends on monolayer ﬂuidity and can be correlated directly
with the carbon-deuterium order parameter of the lipid tails. We ﬁnd
in our simulations, under small negative surface tension, that folding
occurs when the average order parameter is less than ∼0.331.
Unsaturated phospholipids (POPG) and surfactant proteins (SP-B
and SP-C) ﬂuidize the monolayer, while palmitic acid (PA) displays a
charge-dependent condensing affect on DPPC monolayers containing
SP-C. The extent to which the peptides ﬂuidize the monolayer, and
thus enable folding, depends on the hydrophobic character of the
peptides. The peptides appear to provide a larger driving force for
folding than does POPG, allowing fold formation to occur for peptide-
containingmonolayers under conditions for which it does not occur in
the presence of POPG alone. The formation of a lipid bridge by peptide-
mediated fusion and the ensuing redistribution between monolayers
upon re-expansion demonstrate the fusogenic abilities of the peptides
and their role in surface reﬁning. Despite limitations resulting from
potential system size and time scale effects, CG simulation is a valuable
tool for studying the structural transitions of lipid/peptide ﬁlms and
can be used to identify pertinent interactions that may act as driving
forces for these transitions. Our results show that the MARTINI model
can capture qualitatively the effects of lipid and protein components
on the ﬂuidity and collapse behavior of the monolayer in good
agreement with experimental observations.
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